Researchers are testing CAR T cell therapy as a way to reset the immune system in lupus, Graves’ disease and other conditions where the body’s defenses go rogue
The Belgian pharma is buying a two-year-old San Diego biotech for $2bn upfront, the second TCE bet it has placed in months. The thesis: B-cell killers built for cancer can rewire how autoimmune diseases are treated. Candid Therapeutics is two years old.…
A revolutionary cancer treatment is now being applied to a wide range of autoimmune disorders. Columnist Michael Le Page finds it is proving to be even more effective than expected
A woman with three different autoimmune conditions had all of them treated simultaneously by genetically modifying her immune cells to kill off the rogue ones causing problems
